RxDoctor Payments Data

William Mallonee

Neurology · Hutchinson, KSNPI 1730150467

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,199 of the $1,550 with a category attached, or 77.3%. AbbVie accounts for 74.2% of it on its own, with 12 other manufacturers making up the rest.

$1,550in general payments, 2019–2025

Across 31 payments — averaging $50.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novartis$135
  • Acorda Therapeutics, Inc$49
  • Sunovion Pharmaceuticals Inc.$40
  • Amneal Pharmaceuticals LLC$32
  • Genentech USA, Inc.$31
  • plus $113 from 7 others
$1,122,720in research payments, 2019–2025

Across 236 payments — averaging $4757.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurocrine Biosciences, Inc.$943K
  • F. Hoffmann-la Roche AG$173K
  • Genentech, Inc.$8K

What the payments were for

  • Speaking & faculty fees$1,19977%
  • Food & beverage$35123%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,550 in reported general payments places this provider in the 60th percentile of 131 neurology providers in Kansas.

See all neurology providers in Kansas

Other neurology in Hutchinson

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →